NEAT1 and gastric cancer: Additionally, several studies have revealed that targeting lncRNA NEAT1 (121), NONHSAT160169.1 (81), FUAT1 (122), HOTAIR (123) also reversed drug resistance in GC, providing promising therapeutic strategies in cancer therapy.